More Articles

Also noted on biosimilars: 13 April 2012 Biosimilars/General | Posted 13/04/2012

Palivizumab biosimilar successfully produced in plantsBiotechnology company iBio, self-professed leader in the plant-made pharmaceutical field, announced on 10 April 2012 that it had successfully...

Also noted on generics: 13 April 2012 Generics/General | Posted 13/04/2012

Patents on Taxotere invalidOn 9 April 2012, two patents for sanofi-aventis’ cancer drug Taxotere (docetaxel) were ruled invalid and unenforceable by a US court, coming as good news for generics ma...

Generic quetiapine launched but the fight goes on Generics/News | Posted 13/04/2012

The news of AstraZeneca’s failed attempts to delay generic competition for its blockbuster antipsychotic drug Seroquel (quetiapine fumarate) has caused a gold rush among generic companies, who are...

Also noted on pharma: 13 April 2012 Pharma News | Posted 13/04/2012

Drug shortages increase again in 2011Despite efforts by FDA the number of drugs in short supply has increased again in 2011, according to data from the University of Utah, USA. Levels are more tha...

FDA approves first generics to treat high blood pressure and kidney disease Generics/News | Posted 13/04/2012

On 2 April 2012, Teva Pharmaceutical Industries (Teva) announced that it had launched generic versions of sanofi-aventis’ high blood pressure treatments Avapro (irbesartan) and Avalide (irbesartan...

Tighter EU rules on pharmacovigilance for biologicals Policies & Legislation | Posted 06/04/2012

Last updated: 11 March 2013The new EU pharmacovigilance legislation which comes into force in July 2012 will include a tightening of requirements relating to product information and identification,...

Patients do not talk about generics with doctors Generics/Research | Posted 06/04/2012

One of the main financial concerns expressed by adults in the US is the cost of medications and medical bills, however, despite this fact, very few patients talk about the price of prescription med...

Current and future issues surrounding biosimilars Biosimilars/Research | Posted 06/04/2012

Biological medicines are already becoming an increasingly important part of health care. With patent expiries on originator biological products, biosimilars are also increasingly become a part of t...